Keerthika M. Subramanian
Let's Connect
A graduate of Yale Law School, Keerthika is a Chicago and New York-based capital markets partner with a proven track record of success leading some of the legal industry’s most complex, challenging, bespoke, mission critical, and transformative transactions. The general counsel of a public company client described her as “most impressive and quite the dynamo”, while the general counsel of a leading Wall Street asset management firm described her as having “great judgment that balances legal possibilities with commercial reality.” The global head of restructuring and special situations and management committee member of a leading Wall Street investment bank described her as a “star in the making, if not one already.”
Key Matters
Some of the experience represented below may have been handled at a previous firm.
Select representative matters include:
Healthcare/Biotechnology/Life Sciences Capital Markets
- Goldman Sachs in a follow-on offering by Achillion Pharmaceuticals, a company focused on the development and commercialization of therapeutics for infectious diseases (later acquired by Alexion), and the concurrent sale by Johnson & Johnson Innovation Corporation of its entire stake in Achillion Pharmaceuticals
- J.P. Morgan in follow-on offerings by Acceleron Pharma, a company focused on the development and commercialization of therapeutics for rare and serious diseases (later acquired by Merck) and Myovant Sciences, a company focused on the development and commercialization of treatments for women’s health and endocrine disorders
- Jefferies in follow-on offerings by Miragen, a company focused on the development and commercialization of therapeutics for rare diseases, and KalVista Pharmaceuticals, a company focused on the development and commercialization of small molecule protease inhibitors for diseases with unmet need
- Cowen in various follow-on offerings by Viveve Medical, a medical device manufacturer with a focus on women’s health
- Cowen in a follow-on offering by Rocket Pharmaceuticals, a company focused on developing gene therapies for patients with devastating diseases
- Leerink in follow-on offerings by UniQure, a global leader in gene therapy, Vericel, a manufacturer of advanced cell therapy products for sports medicine and severe burn care, and ArQule, a company focused on development of targeted therapeutics to treat cancers and rare diseases (later acquired by Merck)
- Canaccord Genuity in follow-on offerings by Histogenics, a developer of restorative cell therapies for orthopedic conditions (later merged with Ocugen), STAAR Surgical, a manufacturer of eye lenses, and Ampio Pharmaceuticals, a company focused on the discovery and development of novel therapies for inflammatory conditions
- PCI Pharma, a Kohlberg portfolio company and leading provider of integrated pharmaceutical development services to the global healthcare market, on its issuance of new Series B Preferred Stock to finance its acquisition of LSNE, a contract development and manufacturing organization
- NuCana plc, a U.K.-based life sciences company focused on transforming some of the most widely prescribed chemotherapy/cancer agents, in its initial public offering on the Nasdaq
- Molecular Templates, a company developing engineered toxin bodies for the treatment of cancers, in a confidentially marketed public offering
- Immunogen, a biotechnology company focused on the development of antibody-drug conjugate therapeutics for the treatment of cancer (later acquired by AbbVie), in connection with a debt exchange
- Microbot Medical, a developer of robotic medical devices, in connection with equity offerings
- Qiagen N.V., a provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research (later acquired by Thermo Fisher Scientific), in a variety of corporate governance matters
- Truven Health Analytics, a leading provider of cloud-based healthcare data, analytics and insights (later acquired by IBM Watson Health), in a variety of corporate governance matters
- The underwriters in the initial public offering of FibroGen, a developer of treatments for life-threatening or debilitating conditions such as anemia in chronic kidney disease, chemotherapy induced anemia and pancreatic cancer
- Rotech Healthcare Holdings, a leading national provider of home medical and healthcare equipment, in its attempted initial public offering
- The underwriters in the attempted initial public offering of Alzheon, a company focused on developing therapeutics for patients with Alzheimer’s disease and other neurological and psychiatric disorders
Technology and Telecommunications Capital Markets (Cybersecurity, AI-driven applications, Cloud applications, Digital offerings/applications, Software as a service (“SaaS”), enterprise resource planning (“ERP”), E-Commerce, Semiconductors/WiFi and Communications Solutions)
- Fathom Digital Manufacturing Corporation, a leading on-demand digital manufacturing platform in North America, in its Rule 13e-3 “take private” transaction
- Groupon, Inc., a leading global e-commerce marketplace, in its significantly oversubscribed fully backstopped equity rights offering
- Altimar Acquisition Corp. II, a special purpose acquisition company backed by HPS Investment Partners, in its $1.5 billion business combination with Fathom Digital Manufacturing Corporation, a leading publicly traded on-demand digital manufacturing platform in North America
- TeraWulf, Inc., a public infrastructure-focused bitcoin mining company, in connection with several complex equity and debt capital raises
- Comcast Corporation, a multinational telecommunications and media conglomerate, in connection with registered debt offerings totaling over $4.0 billion
- China Investment Corporation, China’s largest sovereign wealth fund, in connection with its Series C investment in Unity Technologies, the world's leading platform for creating and operating interactive, real-time 3D (RT3D) content
- A360 Media, LLC, formerly American Media, Inc., a privately held American media conglomerate, in connection with several complex debt transactions
- The underwriters in the convertible debt offering by Integrated Device Technology, a leading public semiconductor company (later acquired by Renesas)
- The underwriters in the initial public offering of Quantenna Communications, a leading WiFi chip/semiconductor company (later acquired by ON Semiconductor)
- The underwriters in the initial public offering of Coupa Software, a leading AI-driven cloud-based business spend management platform (later acquired by Thoma Bravo)
- The underwriters in the initial public offering of Yodlee, a leading fintech company (later acquired by Envestnet)
- The underwriters in the initial public offering of Hortonworks, Inc., a leading big data company (later acquired by Cloudera)
- An ad hoc investor group of first lien lenders of Avaya Holdings Corp., a global leader in communication and collaboration solutions, in connection with the company’s prepackaged Chapter 11 plan
Food & Beverage, Retail and Consumer Products Capital Markets
- KeHE Distributors, LLC, a leading privately held pure-play natural and organic, specialty and fresh products food distributor in North America, in connection with its Rule 144A/Reg S. tack-on offering of $250,000,000 aggregate principal amount of notes.
- KeHE Distributors, LLC, a leading privately held pure-play natural and organic, specialty and fresh products food distributor in North America, in connection with its Rule 144A/Reg. S senior secured high-yield bond offering of $750,000,000 aggregate principal amount of notes.
- Revlon, Inc., a leading beauty company, in its subsidiary’s 2020 successful out-of-court exchange offer for approximately $343 million aggregate principal amount of outstanding 5.75% Senior Notes due 2021, which allowed Revlon to narrowly avoid Ch. 11 bankruptcy
- Revlon, Inc., a leading beauty company, in securities and disclosure-related aspects of its 2022 Chapter 11 Cases in the U.S. Bankruptcy Court for the Southern District of New York
- Revlon, Inc., a leading beauty company, in its at-the-market (“ATM”) program
- Canaccord Genuity in connection with a follow-on equity offering by The Alkaline Water Company, a leading producer of value-added water and functional beverages
Financial Services/Alternative Asset Management Capital Markets
- Altimar Acquisition Corporation, a special purpose acquisition company backed by HPS Investment Partners, in its $12.5 billion three-way business combination with the Dyal division of Neuberger Berman and Owl Rock Capital Group to form NYSE-listed leading asset management firm Blue Owl Capital, Inc. (including the $1.5 billion PIPE to finance the business combination)
- Barclays Bank & plc on a variety of structured products transactions
- NorthStar Realty Finance Corp., a leading diversified commercial real estate, investment and asset management company, in its SEC registered exchange offer
- Acquisition financing in connection with the merger of Knight Capital Group, a global financial services firm, with Getco LLC, one of the world’s largest independent market makers, to form KCG Holdings, an American global financial services firm engaging in market making, high-frequency trading, electronic execution, and institutional sales and trading (later acquired by Virtu Financial)
- The underwriters in the initial public offering of Yodlee, a leading fintech company (later acquired by Envestnet)
Construction/Housing, Industrial Manufacturing, Mining, Energy and Oil/Gas Capital Markets
- Specialty Building Products, LLC, a portfolio company of TJC, L.P. and a leading distributor of specialty building products in North America, in connection with a Rule 144A/Reg. S offering of $510,000,000 aggregate principal amount of 7.750% senior secured notes due 2029 issued by Specialty Building Products Holdings, LLC and SBP Finance Corp., the proceeds of which were used, together with the proceeds of an incremental term loan B add-on facility, to refinance existing debt securities
- United Rentals, Inc., the world’s largest equipment rental company, on a variety of securities transactions and other financings
- The Chatterjee Group and Rhone Capital, leading private equity firms, on a high-yield bond offering to finance their acquisition of the Lummus Technology business, a leading licensor of proprietary petrochemicals, refining, gasification and gas processing technologies from distressed debtor McDermott International
- Maxim Crane, an Apollo portfolio company and one of the largest lifting solutions businesses in North America, in its modified dutch auction tender offer
- HudBay Minerals Inc., a diversified Canadian mining company, on its issuance of Rule 144A/Reg S. high-yield notes
- Acquisition financing in connection with the acquisition of CPG International, a leading building materials maker, by Ares Management and Ontario Teachers’ Pension Plan
Travel/Leisure Capital Markets
- Carnival Corporation & plc, the world’s largest cruise company, in its Rule 144A offering of first-priority senior secured high-yield notes, its Rule 144A offering of convertible senior notes and its registered offering of common stock
- Carnival Corporation & plc, the world’s largest cruise company, in a complex and novel COVID-19 pandemic related SEC registered direct offering and concurrent repurchase and retirement of a substantial portion of its convertible debt